Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.18 HKD | -1.62% | +2.01% | -38.67% |
May. 15 | Legend Expects to Log Profit in 2026 | MT |
May. 14 | Legend Biotech's Loss Narrows in Q1 as Revenue Surges | MT |
Business Summary
Number of employees: 6,937
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life-science Services and Products
48.2
%
| 2,739 | 55.9 % | 3,167 | 48.2 % | +15.62% |
Cell Therapy
33.9
%
| 914 | 18.6 % | 2,231 | 33.9 % | +144.18% |
Biologics Development Services
12.7
%
| 941 | 19.2 % | 835 | 12.7 % | -11.23% |
Industrial Synthetic Biology Products
5.1
%
| 299 | 6.1 % | 336 | 5.1 % | +12.18% |
Operation Unit
0.1
%
| 7 | 0.1 % | 4 | 0.1 % | -42.83% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
60.3
%
| 2,600 | 53.1 % | 3,961 | 60.3 % | +52.32% |
China
19.4
%
| 1,306 | 26.7 % | 1,273 | 19.4 % | -2.54% |
Europe
11.9
%
| 417 | 8.5 % | 779 | 11.9 % | +86.73% |
Asia Pacific (excluding China)
6.3
%
| 462 | 9.4 % | 417 | 6.3 % | -9.81% |
Others
2.2
%
| 114 | 2.3 % | 143 | 2.2 % | +25.58% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Weihui Shao
CEO | Chief Executive Officer | - | 22-12-31 |
Ye Wang
FOU | Founder | 55 | 01-12-31 |
Shiniu Wei
DFI | Director of Finance/CFO | - | - |
Jian Ge Meng
CHM | Chairman | 55 | 10-03-31 |
Li Zhu
BRD | Director/Board Member | 74 | 09-12-31 |
Berkan Unal
PRN | Corporate Officer/Principal | - | - |
Jing Jing Hua
AUD | Comptroller/Controller/Auditor | - | - |
Wai Ling Wong
SEC | Corporate Secretary | 45 | 15-08-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Xin Guo
BRD | Director/Board Member | 61 | 15-08-23 |
Li Zhu
BRD | Director/Board Member | 74 | 09-12-31 |
Yue Xin Pan
BRD | Director/Board Member | 65 | 15-08-23 |
Xue Hai Wang
BRD | Director/Board Member | 50 | 20-11-21 |
Jia Fen Wang
BRD | Director/Board Member | 73 | 18-11-25 |
Fang Liang Zhang
CEO | Chief Executive Officer | 59 | 01-12-31 |
Lu Quan Wang
FOU | Founder | 54 | 01-12-31 |
Ye Wang
FOU | Founder | 55 | 01-12-31 |
Jian Ge Meng
CHM | Chairman | 55 | 10-03-31 |
Jiu An Pan
BRD | Director/Board Member | 56 | 18-11-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,124,052,670 | 1,147,708,091 ( 54.03 %) | 0 | 54.03 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
LEGEND BIOTECH CORPORATION 60.32% | 174,497,556 | 60.32% | 3,875,590,719 $ |
Company contact information
Genscript Biotech Corp.
No. 28, Yongxi Road Jiangning Science Park
210000, Nanjing
+86 25 5889 7288
http://www.genscript.comGroup companies
Name | Category and Sector |
---|---|
Pharmaceuticals: Major
| |
Probio Technology Ltd. (George Town)
Probio Technology Ltd. (George Town) BiotechnologyHealth Technology Probio Technology Ltd. (Cayman Islands) is a company based in George Town, the Cayman Islands. |
Biotechnology
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.67% | 3.37B | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- 1548 Stock
- Company Genscript Biotech Corporation